Morgan Stanley sees shares of Doximity rising 48% from here.
Get this delivered to your inbox, and more info about our products and services.
The bank upgraded the digital platform for medical professionals to a strong buy from outperform.
The bank initiated the stock with an outperform rating.
The firm upgraded the stock to overweight from equal weight.
The bank pointed to recent M&A success as a catalyst for the stock.
Josh and Sean revisit their Morgan Stanley play and also give two new names on the Best Stocks list.
The investment bank upgraded the pharma stock to overweight from equal weight.
